Thomas Moriarty has joined Celgene as general counsel and corporate secretary, a role that will see him lead global legal strategy at the US biopharma and serve on its management committee.
“Tom Moriarty brings a wealth of experience in global strategic and legal healthcare management,” said Robert Hugin, chair and CEO of Celgene.
“His extensive legal background, as well as his significant leadership experience will provide new insight and valuable perspective on the increasingly complex global healthcare environment.”
This background includes 12 years at Medco Health Solutions from 2000 to 2012, during which he spent his final four years as general counsel and corporate secretary.
Moriarty held several other legal, regulatory, public policy and corporate governance positions at Medco including president, global pharmaceutical strategies; senior VP, pharma strategies and solutions; and senior VP of business development.
Prior to joining Medco, he served as assistant general counsel - pharma and North America for Merial Limited, a Merck & Co and Aventis Company, and as senior attorney for Merck.
No results were found
Blending brilliant writing with in-depth market access and reimbursement expertise...